KRM-III

• Description :

  KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 μM.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  252.33

• Molecular Formula :

  C15H12N2S

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  79220-94-3